1149819

Ahmed M. Awad, DO — FEI 3018005872

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 6, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Kansas City, MO (United States)

Additional Details

Clinical Investigator (CI)